Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA
Published April 24, 2019 · Recall initiated: April 11, 2019
Summary
FDA records drug Class II recall D-1133-2019, published April 24, 2019 and initiated April 11, 2019. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 33,958 bottles; Lot: Lot #: a) C802629, Exp. 03/2020; C805680, Exp. 07/2020, C808821,Exp. 10/2020; b) C806561, Exp. 10/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Product was distributed to major distributors and retailers who may have further distribute the product throughout the United States.
- Lot
- Lot #: a) C802629, Exp. 03/2020; C805680, Exp. 07/2020, C808821,Exp. 10/2020; b) C806561, Exp. 10/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVarenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJDecember 17, 2025
- FDASuccinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, ForOctober 15, 2025
- FDAOmeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy'sJuly 23, 2025
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDAVolumex (Iodinated I 131 Albumin) Injection USP, 25 uCi per 1 mL syringe, Rx Only, Manufactured for DaxorApril 24, 2019
- FDAGravity IV Set with 3-port Closed Stopcock Manifold Model CM42500E-07April 17, 2019
Questions about this recall
Was Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA recalled?
Yes. FDA published recall D-1133-2019 on April 24, 2019. Reported hazard: cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
What should I do if I have this product?
Voluntary: Firm initiated · Letter